Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 201.29

+0.2%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B.D. who wrote (19980)	5/4/1998 9:06:00 AM
From: Henry Niman	Read Replies (2) of 32384

LGND has a very broad anti-angiogenesis program that targets MMPI's among other things (also selectins). The goal is to cut off blood supply and inhibit formation of new blood vessels by blocking MMPs (matrix metalloproteins). Other companies have similar approaches. Roche recently ended its MMPI program with AGPH and BBIOY has nose dived recently. Actually, the price jump in ENMD this morning is remarkably similar to BBIOY's rise several years ago following CNBC's Joe Kernan's comments (I think that BBIOY went from around $12 to triple digits in one day).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next